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Abstract
Background: Cardiovascular instability is common in critically ill children. There is a scarcity of published high-
quality studies to develop meaningful evidence-based hemodynamic monitoring guidelines and hence, with the
exception of management of shock, currently there are no published guidelines for hemodynamic monitoring in
children. The European Society of Paediatric and Neonatal Intensive Care (ESPNIC) Cardiovascular Dynamics section
aimed to provide expert consensus recommendations on hemodynamic monitoring in critically ill children.
Methods: Creation of a panel of experts in cardiovascular hemodynamic assessment and hemodynamic monitoring
and review of relevant literature—a literature search was performed, and recommendations were developed
through discussions managed following a Quaker-based consensus technique and evaluating appropriateness using
a modified blind RAND/UCLA voting method. The AGREE statement was followed to prepare this document.
Results: Of 100 suggested recommendations across 12 subgroups concerning hemodynamic monitoring in
critically ill children, 72 reached “strong agreement,” 20 “weak agreement,” and 2 had “no agreement.” Six
statements were considered as redundant after rephrasing of statements following the first round of voting. The
agreed 72 recommendations were then coalesced into 36 detailing four key areas of hemodynamic monitoring in
the main manuscript. Due to a lack of published evidence to develop evidence-based guidelines, most of the
recommendations are based upon expert consensus.
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Conclusions: These expert consensus-based recommendations may be used to guide clinical practice for
hemodynamic monitoring in critically ill children, and they may serve as a basis for highlighting gaps in the
knowledge base to guide further research in hemodynamic monitoring.
Keywords: Hemodynamic monitoring (HD), Paediatric intensive care unit (PICU), Children, Cardiovascular instability,
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Introduction
Circulatory shock is defined as a “life-threatening generalized
the maldistribution of blood flow resulting in failure to de-
liver and/or utilize the adequate amount of oxygen, leading
to tissue dysoxia” [1]. Cardiovascular instability with or with-
out shock is common in children admitted to pediatric inten-
sive care units. Over half of the children with hemodynamic
instability in intensive care units have multiple-organ dys-
function and sepsis remains the leading cause [2]. Similarly, a
multi-center international study (Sepsis Prevalence, Out-
comes, and Therapies; SPROUT) reported that over two
thirds of children with sepsis had multiorgan dysfunction,
which was associated with a very high mortality. These data
are similar to what has been described in the adult popula-
tion [3]. However, there remains a paucity of data regarding
the epidemiology of circulatory derangement in children and
how best hemodynamic status can be evaluated or moni-
tored in the pediatric intensive care units.
Multiple studies have established that early recognition
and treatment of pediatric circulatory insufficiency or
shock are crucial to improve survival. However, the opti-
mal way to resuscitate children with circulatory failure is
controversial. The exact order and quantity of fluids or
vasoactive drug administration in the critically ill child
with shock is supported by little evidence, although there
are several consensus statements [4, 5].
Overzealous fluid resuscitation is detrimental to some
children [6, 7]. There is some consensus regarding the first-
line treatment in patients with shock or significant
hemodynamic instability, but debate remains concerning
how much fluid should be administered, which type of
vasoactive drug should be used, how to assess the
hemodynamic changes, and ultimately what hemodynamic
clinical goal should be targeted to guide optimal treatment.
Ideal hemodynamic monitoring should accurately deter-
mine the severity of circulatory derangement and illustrate
the underlying pathophysiologic mechanism to enable the
clinician to choose the most appropriate treatment and to
guide the therapy [7, 8]. Furthermore, hemodynamic moni-
toring can provide useful information about the circulatory
condition in almost all types of life-threatening shock. This
can be hemodynamic instability as a result of major surgery,
cardiac failure, trauma, sepsis, or other causes of shock in
children. The current guidelines mostly focus on early
recognition and treatment but do not specify the type of
monitoring technology that can or should be used under
various circumstances. There are still no published
evidence-based or even consensus guidelines specifically for
hemodynamic monitoring in neonates and children. How-
ever, there is a wide range of devices and techniques avail-
able to evaluate the hemodynamic status and an increasing
number of these methods have become available for use in
children. In the annual meeting of the European Society of
Paediatric and Neonatal Intensive Care (ESPNIC) in Octo-
ber 2016, members of the Cardiovascular Dynamics Section
were tasked to develop evidence-based guidelines if at all
possible, or an expert consensus statement on the
hemodynamic monitoring specifically for use in children.
Methods
A steering committee (SC) of three lead authors, one
pediatric intensivist/anesthesiologist (JL), one neonatolo-
gist/pediatric cardiologist (YS), and one pediatric intensivist
(JU), identified nine expert panel members who signifi-
cantly contributed with publications in hemodynamic mon-
itoring or cardiovascular status assessment in children in
the last 10 years, similarly to what had been done with pre-
vious ESPNIC guidelines [9–11]. Further, the three selec-
tion criteria for inclusion as panel member were (1) must
be clinicians working in a pediatric or neonatal intensive
care, (2) needed to have experience with some form of HD
monitoring, and (3) should have published in peer-
reviewed journals concerning the topic. Panelists’ selection
was performed prior to the literature search, and for logistic
reasons, the number of participants was limited to a max-
imum of 12. All invited experts agreed to participate.
The working group had face-to-face meetings during
the ESPNIC conference in Lisbon 2017 and the European
Academy of Paediatric Societies (EAPS) conference in
Paris in 2018 and unanimously agreed to provide recom-
mendations from full-term infants over 37 weeks of gesta-
tion and over 4 weeks of postnatal age (lower limit) to
18 years old (upper limit), in order not to overlap with
preterm-neonatal and adult guidelines. The panel subdi-
vided hemodynamic monitoring into 12 subgroups: arter-
ial blood pressure, central venous pressure, pulmonary
artery catheter, cardiac output, transpulmonary thermodi-
lution, central venous oxygen saturation measurement,
lactate levels, clinical signs, near-infrared spectroscopy,
Singh et al. Critical Care          (2020) 24:620 Page 2 of 13
fluid responsiveness, microcirculation, and role of
ultrasonography.
Panel members were assigned in pairs to one of the sub-
groups, and each subgroup was coordinated by one of the
steering committee members. The tasks of each subgroup
consisted of performing a thorough review of the literature,
writing a short description of the parameter/method, the
technical background and physiological basis, writing a
short overview of the reliability of the method if applicable,
establishing, when possible, normal or target values, esti-
mating the clinical value of the method, or parameter in re-
lation to the patient categories mentioned. Because of the
hemodynamic knowledgeable background of the panel
members, these documents served as an overview to pro-
vide the entire panel with recent collective knowledge. The
documents were not intended as a structured systemic re-
view of the specific technology or method. Also, given that
there is only low-quality data available in many aspects of
hemodynamic monitoring in children, and that the focus of
this work was to reach a consensus within the panel of ex-
perts, the working group decided not to use the GRADE
system to evaluate the literature [12]. The definition of
hemodynamic instability was not ill-defined but intended as
a clinical description reflecting the child in need for fluid
resuscitation or vasoactive drugs.
Finally, 3 types of recommendations were formulated
as follows: (1) recommendations considering the reliabil-
ity of methods, but only if applicable; (2) recommenda-
tions considering normal or target values, but only if
applicable; and (3) recommendations considering clinical
use in relation to specific patient groups.
The setup and some proposed recommendations were
discussed in a face-to-face meeting during the European
Academy of Pediatric Societies (EAPS) in Paris, France
(October 2018). In May 2019, an anonymous electronic
voting system (Survey Monkey®, San Mateo, USA) was
used to vote on all recommendations by each panel mem-
ber including the SC. Each panel member was given ac-
cess to all the work from other subgroups with text,
results, and full-text publications in order to vote with all
available evidence. Panel members scored all the recom-
mendations individually from 1 (complete disagreement)
to 9 (complete agreement). The median score was calcu-
lated after eliminating one lowest and one highest value.
Recommendations were labeled “strong agreement” (me-
dian 7–9 and with no individual score < 7), “equipoise”
(median 4–6), or “disagreement” (median 1–3).
All recommendations that reached “strong agreement”
in the first voting round according to the above scoring
system acquired the strong agreement label. All recom-
mendations that reached “equipoise” or “disagreement” in
the first voting round were discussed and rephrased in the
panel meeting during the ESPNIC conference in Salzburg,
Austria (June 2019). The revised recommendations
underwent the same voting process as in the first round.
The revised recommendations retaining “strong agree-
ment” after the second electronic voting were labeled as
“weak agreement.” All other revised recommendations
were classified as “no agreement.” Guidelines have been
prepared according to the international Appraisal of
Guidelines, Research and Evaluation (AGREE) [13].
Results
One hundred recommendations were drafted and voted by
the panel for the level of agreement. Seventy-two recom-
mendations reached “strong agreement” after the first
round. The remaining 28 recommendations, where no
“strong agreement” was reached, were discussed in a face-
to-face panel meeting during the ESPNIC conference in
Salzburg, Austria (June 2019): 21 were rephrased for 2nd
round of voting, one was designated as “no agreement,”
and panel proposed deleting 6 recommendations as they
were thought to be redundant after discussing all other rec-
ommendations (Fig. 1).
Finally, of the total 94 recommendations, 72 reached
“strong agreement,” 20 “weak agreement,” and on 2 pro-
posed recommendations “no agreement” was reached as
summarized in “Supplementary file - Table 1.”
Discussion and evidence for the recommendations
The details of technique, methods, reliability, search for
published evidence, and references are provided in the on-
line supplement (https://doi.org/10.1186/s13054-020-
03326-2). The commonly used parameters for
hemodynamic monitoring in critically ill children are mea-
surements of the blood pressure, central venous pressure
(CVP), central venous oxygen saturation, cardiac output,
serum lactate, pulmonary artery catheter, transpulmonary
dilution, clinical signs, near-infrared spectroscopy, fluid
responsiveness, microcirculation, and role of ultrasonog-
raphy A brief summary of the evidence related to each
sub-section has been summarized below.
Clinical signs
Pediatric resuscitation courses (such as ETAT WHO,
APLS) teach initial assessment of the shocked child well.
Most caregivers will be familiar with the clinical signs and
symptoms that help assess the hemodynamic status in chil-
dren, including heart rate (HR), blood pressure, respiratory
rate (RR), state of consciousness, diuresis, core and periph-
eral temperature, capillary refill time, and peripheral perfu-
sion. Some of these parameters are age-dependent, and
some can be altered by ambient temperature, pain, anxiety,
and many other factors. The mission of the primary resus-
citation team is to identify the shocked child in need for ur-
gent intervention and treatment, usually with fluids and
then inotropes or vasopressors in some combination.
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All recommendations reached a high level of agree-
ment, both in identifying children in need for treatment
and in the limited value of clinical signs to guide
hemodynamic treatment. There is a significant variability
in clinicians’ abilities to assess hemodynamic clinical pa-
rameters at the bedside. Early signs of hemodynamic de-
compensation may be subtle and can be easily missed by
the clinicians [14]. For these reasons, the frequent and
trend evaluation of clinical signs are more important
than a single specific determination. A combination of
vital signs can be more useful to evaluate hemodynamic
state than individual parameters [15].
Disappointingly, there is no good correlation between clin-
ical assessment and invasive hemodynamic parameters,
which only indicates that clinical parameters and invasive pa-
rameters do not measure the same compartment [16].
Hence, in hemodynamically unstable patients apart from fre-
quent meticulous assessment, monitoring trends of several
measurable clinical, biochemical, and monitoring parameters
should be used to guide the therapy timely and accur-
ately (Table 1).
Arterial blood pressure
Blood pressure (BP) measurement is one of the most com-
monly used hemodynamic parameters for diagnostic and
therapeutic decisions in critically ill children, not least due
to ease of utilization and, if invasive, the additional benefit
of arterial blood sampling, as well as continuous data sam-
pling. Both a low and a high BP on admission are related
to an increased mortality [17]. Accurate measurement of
BP is considered essential for the diagnosis and treatment
of hypertension as well as of hypotension, including
Fig. 1 Flow chart of the methodology used in consensus development
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various categories of hemodynamic shock [18, 19]. BP can
be measured invasively but also by using several less reli-
able non-invasive methods [20].
The committee strongly agreed on the use of intra-
arterial blood pressure (IBP) over oscillometric blood
pressure (OBP) measurement when there is a need for
reliable BP measurement in children with shock not
responding to initial fluid therapy or requiring inotropes
or vasoactive medication; in patients with intracranial
hypertension and intracranial pressure monitoring to
measure cerebral perfusion pressure; during major sur-
gery and in children with malignant hypertension or
other hypertensive emergencies and to monitor the ef-
fect of continuous intravenous vasoactive medications or
inotropes. However, the clinical value of BP in guiding
hemodynamic therapy was not appreciated equally
among the panel members. Nevertheless, there was
strong agreement that BP should not be used as the only
therapeutic target in unstable children, so the
hemodynamic state should be evaluated integrating BP
with several clinical and additional hemodynamic pa-
rameters [21].
Optimal values for BP in healthy and critically ill
children, including therapeutic thresholds, should be
related to the clinical condition, age, sex, and body
size [20–25]. There was only weak agreement con-
cerning BP values in children under 12 years of age.
In children over 12 years of age generally, we strongly
recommend a target mean arterial pressure (MAP) of
≥ 65 mmHg, although in specific situations, the tar-
geted BP may be higher such as when managing
raised intracranial pressure.
Central venous pressure (CVP)
The committee shared a strong common opinion regard-
ing CVP. CVP should be measured as accurately as pos-
sible and be evaluated only as part of multi-modal
hemodynamic monitoring to assess the intravascular vol-
ume and cardiac function [26, 27]. Isolated CVP measure-
ment is of limited value but trends of CVP, both the value
and the wave morphology, or change in CVP in response
to fluid or vasoactive therapy may provide useful informa-
tion about the overall hemodynamic status and cardiovas-
cular physiology in critically ill children. Specifically, a rise
or high levels of CVP should be avoided [28]. The com-
mittee agreed that CVP is not of great value in the initial
treatment of critically ill children, but it can deliver im-
portant additional information in children with shock re-
fractory to initial hemodynamic treatment; however, the
use of CVP requires a good understanding of its limita-
tions and pathophysiology of underlying disease process.
For example, CVP should not be used as a sole parameter
to guide fluid therapy [29–32].
Central venous oxygen saturation measurement
Central venous oxygen saturation (ScvO2) approximates
but does not equal mixed oxygen saturation (SmvO2). The
normal ranges for ScvO2 and SmvO2 are 70–80% and 60–
70%, respectively, in the setting of a normal aortic satur-
ation [33, 34]. Trends between ScvO2 and SmvO2 are often
interchangeable, although SmvO2 values are generally
around 7–10% lower than ScvO2. A low ScvO2 typically in-
dicates a mismatch between oxygen supply and utilization.
Conversely, a normal, or high ScvO2 value, does not neces-
sarily signify supply-demand adequacy, as tissue dysoxia
Table 1 Recommendations on use of clinical examination and blood pressure measurement in hemodynamic monitoring in
critically ill children
Sr No Recommendation Level of agreement
Clinical signs
1. There is no single clinical parameter that allows to evaluate the global hemodynamic status in children
and, therefore, we recommend to analyze several parameters and make frequent assessments.
Strong agreement
2. We recommend to perform a clinical assessment as the initial evaluation in all patients for the detection
of hemodynamic alterations and to evaluate clinical signs periodically together with hemodynamic
monitoring parameters in unstable patients.
Strong agreement
3. We do not recommend to titrate hemodynamic therapy or fluid loading solely based upon clinical signs
or a reduced urine output alone in unstable patients with the exception of the initial resuscitation phase.
Strong agreement
Arterial blood pressure
4. We recommend the use of intra-arterial blood pressure (IBP) over oscillometric blood pressure (OBP)
measurement when a reliable blood pressure (BP) measurement is of importance or when fast changes
in blood pressure need to be detected.
Strong agreement
5. In children over 12 years of age we recommend a target blood pressure of ≥ 65 mmHg MAP (according
to adults surviving sepsis guidelines) unless in children known to have prior hypertension.
Strong agreement
6. We recommend not to use BP as the only therapeutic target in unstable children. The hemodynamic
state should be evaluated integrating several clinical and hemodynamic parameters.
Strong agreement
7. We recommend IBP monitoring in children in shock not responsive to initial fluid therapy or requiring
vasopressor treatment, and hypertensive emergencies to control the effect of continuous invasive
hypotensive drugs.
Strong agreement
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(which may occur in sepsis) may cause an artificial eleva-
tion (or normalization) of ScvO2. Lastly, ScvO2 in isolation
cannot be considered a surrogate of cardiac index/cardiac
output [35]. However, there is some evidence that resusci-
tation in sepsis might be more beneficial when ScvO2 is in-
corporated in the treatment strategy [36].
The committee agreed that ScvO2 is an important par-
ameter in unstable patients not responding to the first
treatment and that its trend is helpful in hemodynamic
management. However, we recommend that hemodynamic
therapy should not be targeted solely based upon ScvO2
levels (Table 2).
Volume resuscitation and fluid responsiveness
Volume resuscitation is one of the most commonly used
therapeutic options. Nevertheless, excessive fluid adminis-
tration may impair tissue perfusion even further by pro-
moting edema and third-space fluid accumulation [6, 7,
37]. A rise in cardiac output (or stroke volume) as a result
of volume resuscitation is called fluid responsiveness. To
prevent unnecessary fluid administration, it could be
beneficial to predict fluid responsiveness before the fluids
are delivered. Unfortunately, there is no clear, simple, and
proven method to predict fluid responsiveness in children.
Static measures, mostly CVP, are not appropriate to test
fluid responsiveness [29, 31]. The published evidence sug-
gests that respiratory variation in aortic blood flow peak
velocity {(ΔVPeak/velocity time integral (VTI)} is the most
reliable indicator of fluid responsiveness, but only in venti-
lated children that fulfil various criteria [38]. Other dy-
namic methods, like passive leg raising test and liver
pressure, have not been adequately assessed in children of
all ages [39].
Due to the lack of simple bedside, available methods to
determine fluid responsiveness and the risk of fluid over-
load with aggressive approach, the committee recom-
mended the following: recurrent smaller fluid boluses
(maximal 5–10 ml/kg) in a short-time interval in patients
with hemodynamic instability while tracking changes in
cardiac output, blood pressure, and CVP to confirm or
Table 2 Recommendations on use of measurement of CVP, SCVO2, and prediction of fluid responsiveness in hemodynamic
monitoring in critically ill children
Sr No Recommendation Level of agreement
Central venous pressure
1. We recommend to place the tip of a central venous catheter at the junction of the superior caval
vein (SCV) and the right atrium to obtain an optimal central venous pressure (CVP) measurement
or ScvO2 sample.
Strong agreement
2. We recommend to measure CVP in all unstable patients refractory to initial hemodynamic treatment. Strong agreement
3. We recommend against the use of CVP to predict fluid responsiveness; Fluid loading should not
be started solely based upon a low CVP.
Strong agreement
4. An isolated CVP measurement is of limited value in clinical practice. However, trends in CVP may
provide important information regarding changes in cardiovascular pathophysiology such as evolving
right heart failure and an abrupt elevation in CVP upon fluid administration should raise suspicion
of significant cardiac dysfunction.
Strong agreement
Central venous oxygen saturation measurement
5. We recommend to measure central venous oxygen saturation (ScvO2) in unstable patients not
responding to the initial treatment. ScvO2 < 65% suggest a possible hemodynamic alteration;
however, in sepsis, a normal or high ScvO2 may reflect mitochondrial dysfunction and mask
hemodynamic alterations.
Strong agreement
6. ScvO2 is not an adequate marker of cardiac index (CI). Strong agreement
7. We recommend against targeting hemodynamic therapy solely based upon ScvO2. Strong agreement
Volume resuscitation and fluid responsiveness
8. We recommend to observe the patient’s clinical situation, physical exam, and various perfusion
indicators suggesting an inadequate CO (or oxygen transport) caused by hypovolemia before
considering fluid loading.
Strong agreement
9. In delivering a bolus of fluid, we recommend to administer a small bolus of fluid in a short time
period while tracking changes in cardiac output, blood pressure and CVP, and when possible or
available, to confirm fluid responsiveness before commencing fluid loading therapy.
Strong agreement
10. We recommend alternative therapeutic strategies for hypotension management in fluid non-responders.** Strong agreement
11. We recommend to withhold fluid therapy in patients with an increasing CVP and no significant
increase in blood pressure or cardiac output as a result of previous fluid therapy.
Strong agreement
12. We recommend fluid therapy (with boluses 5–10 ml/kg) as part of early resuscitation in unstable
patients guided by the effect on blood pressure and/or cardiac output.
Strong agreement
**Non-responders defined cases who had no rise in cardiac output (or stroke volume) as a result of volume resuscitation
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assess fluid responsiveness. Furthermore, we strongly
agreed to recommend withholding fluid therapy in
patients with an increasing CVP and no significant in-
crease in blood pressure or cardiac output as a result
of previous fluid therapy. No specific recommenda-
tions regarding estimating fluid responsiveness can be
made in patients with raised intracranial pressure or
extracorporeal life support (ECLS).
Echocardiography/ultrasonography
Cardiac ultrasound or functional echocardiography is non-
invasive and easily available at the bedside in the intensive
care setting, and it allows rapid evaluation of hemodynamic
status in real time. It can be used to assess cardiac function
and preload, to estimate cardiac output and fluid respon-
siveness, to measure pulmonary artery systolic pressure and
serial assessment, and allows to evaluate response to
therapy [10, 40]. Hence, it can be used, as an adjunct to
other parameters, in children with hemodynamic instability
to gain additional information required for making accurate
clinical decisions such as myocardial failure, pulmonary
hypertension, or cardiac tamponade [10]. It can help in un-
derstanding the pathophysiology of shock in children, and
it can help in selecting timely, targeted specific, and right
intervention [10, 41, 42].
The committee strongly recommended the use of car-
diac ultrasound for hemodynamic evaluation of infants
and children with hemodynamic instability. Since cardiac
ultrasonography does not provide continuous measure-
ments and is limited by a wide intra- and inter-observer
variability [40, 43], we strongly recommend using serial
assessments. However, we do not consider cardiac ultra-
sound as a tool for the routine hemodynamic monitoring
in the intensive care setting (Table 3).
Table 3 Recommendations on the use of cardiac ultrasound and other methods to estimate cardiac output for hemodynamic
monitoring in critically ill children
Sr No Recommendation Level of agreement
Echocardiography/cardiac ultrasound
1. We recommend to use cardiac ultrasound as an adjunct to gain additional information
required for making accurate clinical decisions in infants and children with hemodynamic
instability but not as a tool for routine hemodynamic monitoring in intensive care setting.
Strong agreement
2. Cardiac ultrasound can help in diagnosing pulmonary hypertension and assessing severity
of pulmonary hypertension, and in detecting cardiac tamponade.
Strong agreement
3. We recommend monitoring of pulmonary artery pressure (PAP) using ultrasound with
refractory shock states to exclude pulmonary hypertension. Cardiac ultrasound may help
in identifying underlying pathophysiology of shock and choosing the right intervention
based upon deranged hemodynamic physiology (preload, afterload, or cardiac function).
Strong agreement
4. Cardiac ultrasound may help in assessing fluid responsiveness and we recommend using
velocity time integral (VTI) across aortic valve for assessing fluid responsiveness rather than
inferior vena cava collapsibility in mechanically ventilated infants and children.
Strong agreement
5. We recommend using serial longitudinal assessments to assess response to therapy in
patients with significant hemodynamic instability.
Strong agreement
Cardiac output measurement and transpulmonary indicator dilution
6. We recommend to use ultrasound/Doppler-based methods of estimating CO in stable patients,
for the initial assessment of unstable patients and to decide if a more invasive method is
required. When reliable absolute measurements of CO are deemed necessary, thermodilution
(TPD) is the method of first choice.
Strong agreement
7. In patients with a refractory shock when an accurate measurement of CO is needed, we
recommend to use transpulmonary thermodilution (TPTD) or semi-invasive transpulmonary
ultrasound dilution (TPUD).
Weak agreement
8. We recommend to use invasive (and if possible continuous) CO monitoring in unstable
post-operative patients after major (cardiothoracic) surgery, multiple trauma injuries or
burns or patients with complex cardiopulmonary interactions.
Strong agreement
9. We recommend against targeting fluid therapy based upon blood volumes measured with
TPD or targeting hemodynamic therapy based upon lung water measurement to assess
pulmonary edema in critically ill children.
Strong agreement
10. Because of their intermittent measurement technique, TPD methods are not suitable for the
detection of fast changes in CO unless used in conjunction with continuous trend monitoring
using pulse contour analysis, calibrated by transpulmonary indicator dilution technology.
Strong agreement
Pulmonary artery pressure
11. We do not recommend to use pulmonary artery catheter (PAC) to measure CO in children.
However, monitoring of left atrial pressure only in selected cardiac surgery patients or patients
after lung transplant using a surgically inserted catheter can be helpful
Strong agreement
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Cardiac output monitoring and transpulmonary indicator
dilution
Cardiac output (CO) is the product of heart rate and stroke
volume. Stroke volume depends on preload, contractility,
and afterload. The physical examination and simple com-
monly used hemodynamic parameters are the surrogate
markers of cardiovascular well-being, but they do not pro-
vide a direct assessment of the cardiovascular hemodynamic
status of the patient and clinical estimation of cardiac out-
put has showed to be mostly inaccurate [14]. Hence, there
seems to be a need of advanced hemodynamic monitoring
to titrate therapies specifically when volume expansion or
vasoactive drugs are delivered in order to improve cardiac
output or systemic vascular resistance [44, 45]. In patients
with refractory shock, when an effective and accurate meas-
urement of CO is needed, the following methods may be
used depending upon available resources and expertise:
measurement of CO using transthoracic ultrasound (echo-
cardiography) and transpulmonary dilution (TPD) [44–46].
Ultrasonography is non-invasive, easily available, and can
provide a fairly accurate and serial estimation of cardiac out-
put at the bedside to monitor the initial response to therapy
[40, 47]. However, it requires specific skills and it is
operator-dependent. Despite being the most reliable clinical
method to measure cardiac output, the application of TPD
in the clinical practice may be challenging because of
resources, technical difficulties, or lack of expertise. It
is invasive and not suited to emergency resuscitation.
Only two methods are available in children below
40 kg: transpulmonary thermodilution (TPTD) by
PiCCO (Pulsion Medical Systems, Germany) and trans-
pulmonary ultrasound dilution (TPUD) by CO status
(Transonic, USA) [44–46, 48]. Neither is in frequent
use in ICU due to their intricate set-up, and particularly
for PICCO, the risk to children’s vessels from relatively
large femoral arterial catheter required. Moreover, be-
cause of their intermittent measurement technique,
TPD methods are not suitable for the detection of
rapid, frequent, and changes in hemodynamic status, as
required in some critically ill children.
In the clinical practice, we recommend to use cardiac
output ultrasound/Doppler methods for estimating CO
in stable patients and the initial assessment of unstable
patients. The committee did not reach to a strong agree-
ment on the methods to estimate CO in children with
refractory shock needing escalation of treatment and
hemodynamic monitoring. There was a strong agree-
ment that TPD methods are the most reliable but
whether their use should be advised in situations need-
ing escalation only reached a weak agreement. TPD
methods also measure blood volumes and lung water,
but the committee recommended against using these pa-
rameters for targeting hemodynamic goals. Measuring
CO using PAC is not recommended.
Cardiac output can also be estimated at the bedside
using other non-invasive methods like bioimpedance
and bioreactance, pulse contour, and Doppler. Valid-
ation of these methods in critically ill children is sparse,
and these methods are therefore not consensually viewed
as accurate enough to estimate absolute values of CO in
the intensive care setting in children [49]. However, they
might provide a trend over time. In general, the commit-
tee strongly agreed that at the current time no recom-
mendations regarding these methods can be given due
to the limited experiences in critically ill children.
Pulmonary artery pressure (PAP)
The pulmonary artery catheter (PAC) can provide con-
tinuous measurement of right atrial, PAP, measurement
of CO, and pulmonary arterial occlusion pressure (wedge
pressure). However, because of invasiveness and size, it is
not used or recommended in intensive care clinical prac-
tice in children [50]. Similarly, left atrial pressure can be
measured using surgically inserted left atrial catheters
(LAC) [51, 52]. Still, alternative less invasive techniques
are being used in children to estimate left atrial pressure
in unstable patients and LAC or PAC are rarely used in
today’s intensive care clinical practice [53, 54].
Because of the above, the committee recommends not to
use a PAC in children to measure cardiac output or PAP in
the ICU. Instead, transthoracic ultrasound echocardiog-
raphy can be easily used to estimate PAP at the bedside
non-invasively and it can provide serial assessment to
monitor the response to therapy or disease process (as
above). However, it should not be used to estimate PAP in
patients with right ventricular (RV) failure [55]. For precise
measurement of PAP, we recommend using the PAC only
at the cardiac catheterization laboratory.
Lactate measurement
Determination of blood lactate concentration is a cheap,
fast, and easy bedside parameter that has demonstrated util-
ity to predict the outcome or to trigger the need to intensify
medical treatment [56]. The committee showed some vari-
ation in their approach to the use of lactate in children since
5 out of 10 recommendations needed a revision.
In critically ill patients or children with shock, early and
serial lactate blood sampling from a reliable site such as a
central venous or arterial indwelling catheter is recom-
mended, though peripheral venous sampling with tourni-
quet time < 60 s is possible [57]. This is specifically
recommended when the initial capillary lactate value is >
3.0 mmol/L [57–59]. Studies report an association between
failure to normalize lactate levels to a certain threshold
(3.0 ± 1.0 mmol/L) during the first 12 to 24 h of ICU ad-
mission, and adverse outcomes regardless of the reason for
ICU admission [60, 61]. Experts could not agree on the use
of lactate as part of a goal-directed approach and only
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weakly agreed on the approach to a persistent high lactate
level. In the latter, lactate levels should always be used in
conjunction with other clinical indicators of poor systemic
perfusion and monitoring parameters. Persistently elevated
lactate levels may reflect other mechanisms rather than
those derived from poor tissue perfusion in shock and in-
stead reflect aerobic glycolytic mechanisms including cat-
echolamine administration or endogenous release
[62] (Table 4).
Near-infrared spectroscopy
Near-infrared spectroscopy (NIRS) is a non-invasive, bed-
side technique to estimate regional capillary-venous
hemoglobin saturation (rSO2). The mean baseline cere-
bral rSO2 is > 70% in healthy children. Infants and chil-
dren with cyanotic heart disease may have a cerebral rSO2
between 46–57% [63–67]. Moreover, practitioners should
be mindful about a considerable variability in NIRS values
between commercially available devices. It has been ob-
served that values measured in both monitors INVOS
5100-C® (Medtronic; Boulder, CO, USA) and Foresight
Elite® monitor (CAS Medical Systems; Branford, CN,
USA) are not interchangeable [68]. Although NIRS is
mainly used to measure rSO2 in the brain, there are also
reports of its use on other organs. In a study by Dabal
et al. [69], it appears that renal NIRS and inferior vena
cava desaturations precede rScO2 changes in the predic-
tion of serious cardiovascular adverse events in patients
after stage 1 Norwood palliation. Trend in NIRS values
may provide valuable physiological information in chil-
dren with hemodynamic instability although clear (cut-
off) values and evidence of benefit are lacking.
The committee strived to define recommendations with
regard to this subject and 6 out of 7 recommendations had
to be redefined. As a result, the only strong recommendation
was to advise against routine use of NIRS in all children with
hemodynamic instability. Moreover, the committee agreed
not to make recommendations regarding the use of NIRS
while treating children in shock, post-cardiac arrest, post
traumatic brain injury, and infants with hypoxic-ischemic en-
cephalopathy. Lastly, there was no agreement on the clinical
usefulness of a decline of cerebral rSO2 under 40–50% or a
change in baseline of more than 20% [70].
Microcirculation
Microcirculatory assessment by videomicroscopy using
side-stream or incident dark field is expensive and not
widely available. Currently, it does not allow for assess-
ment of rapid circulatory changes during resuscitation
[71]. No studies have defined the normal values of micro-
circulation in children outside the neonatal period but do
report that vascular density seems to decrease with age
[72]. So far, published studies have not defined target
values of microcirculatory parameters in critically ill chil-
dren [72–77]. At this point in time, the committee recom-
mends its use only for research purposes.
The committee also states that many routinely used
parameters like capillary refill, peripheral temperature,
Table 4 Recommendations on use of serum lactate, near infrared spectroscopy (NIRS), and microcirculation assessment for
hemodynamic monitoring in critically ill children
Sr No Recommendation Level of agreement
Serum lactate measurement
1. We recommend to obtain a repeat blood sample from a reliable site when the lactate value
of a capillary sample is higher than 3.0 mmol/L and to closely follow-up patients and intensify
treatment until lactate values at least drop below 3.0 mmol/L, especially if other concerns
regarding tissue hypoxia are present.
Strong agreement
2. We recommend to interpret lactate levels always in conjunction with clinical indicators of
poor systemic perfusion and monitoring parameters.
Strong agreement
Near infrared spectroscopy
3. Trend in NIRS values may provide valuable physiological information in children with
hemodynamic instability but routine use in all children with hemodynamic instability
is not recommended.
Strong agreement
4. Near infrared spectroscopy (NIRS) can be useful during the peri-operative period after surgery




5. Many routinely used parameters like capillary refill, peripheral temperature, lactate, NIRS etc.,
reflect aspects of the hemodynamic condition, but they do not adequately reflect the
microcirculation. Although central venous to arterial CO2 difference could provide additional
insight into the microcirculatory condition, we recommend against its use to guide resuscitation
in critically ill children
Strong agreement
6. We recommend against routine microcirculation evaluation by video microscopy in stable children
except those in clinical studies
Strong agreement
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and lactate may reflect aspects of the hemodynamic con-
dition but do not adequately reflect the microcirculation
and cannot be used as such. Although central venous to
arterial CO2 difference could provide additional insight
into the microcirculatory condition, we currently recom-
mend against its use to guide resuscitation in critically ill
children.
Limitations
We acknowledge the limitations of these recommenda-
tions as follows: (1) The most important limitation is the
lack of high-quality evidence. These recommendations
are based upon expert consensus and review of the pub-
lished literature including experts’ opinions, which can
involve subjective value judgments; (2) both lower and
upper limits of age, from term infant > 37 weeks and
postnatal age > 4 weeks to 18 years, are artificial—to
avoid overlapping with neonatal and adult population-
specific guidelines; and (3) some of these recommenda-
tions may not be appropriate for low-resource settings
and may not be applicable in all settings requiring
hemodynamic monitoring in children because of their
limited availability or expertise.
Nevertheless, despite these limitations, the committee
members believe that these are consensual expert recom-
mendations based upon literature review and rigorous
standardized process of developing expert consensus—
followed the DELPHI approach, a well-established stan-
dardized approach (DELPHI approach)—to reach consen-
sus in such circumstances of limited published evidence
to develop evidence-based guidelines.
Future directions
The committee recognizes that there is an important lack
of knowledge and evidence concerning hemodynamic
monitoring in children. There is a great need for (1) study-
ing the relationship between measured parameters and
end-organ perfusion, and (2) evaluating the clinical effi-
ciency and patient outcome when therapy is guided by
specific monitoring technologies.
Conclusions
Cardiovascular instability is common in children admit-
ted to pediatric intensive care. Multiple-organ dysfunc-
tion is commonly associated with cardiovascular
derangements in patients with shock and carries high
mortality. Effective hemodynamic monitoring can help
in identifying cardiovascular instability early and choos-
ing the appropriate targeted therapy timely. Currently,
with the exception of management of shock, there are
no published HD monitoring guidelines for critically ill
children, and the published evidence remains scarce.
These are therefore the first expert consensus recom-
mendations for HD monitoring in critically ill children
with hemodynamic instability. These recommendations
can help clinicians in their clinical practice and may be-
come the frame for future research aiming at providing
strong data for evidence-based guidelines in this field.
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